| 2020 | Non-absorbable versus absorbable sutures for anterior colporrhaphy: study protocol for a randomised controlled trial in South Korea
| BMJ OPEN |
| 2021 | Non-alcoholic fatty liver disease in polycystic ovary syndrome women
| SCIENTIFIC REPORTS |
| 2022 | Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2011 | Non-invasive prediction of intra-amniotic inflammation in women with preterm labor
| ULTRASOUND IN OBSTETRICS & GYNECOLOGY |
| 2015 | Noninvasive prenatal diagnosis of duchenne muscular dystrophy: comprehensive genetic diagnosis in carrier, proband, and fetus
| CLINICAL CHEMISTRY |
| 2023 | Novel Inhibitor of Mixed-Lineage Kinase Domain-Like Protein: The Antifibrotic Effects of a Necroptosis Antagonist | ACS Pharmacology & Translational Science |
| 2011 | Obstetric and perinatal outcomes of dichorionic twin pregnancies according to methods of conception: spontaneous versus in-vitro fertilization | TWIN RESEARCH AND HUMAN GENETICS |
| 2013 | Obstetrics & Gynecology Science, on the runway
| Obstetrics & Gynecology Science |
| 2021 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial | LANCET ONCOLOGY |
| 2018 | Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF | CELL DEATH AND DIFFERENTIATION |
| 2020 | Operative hysteroscopy-assisted pregnancy termination after failed surgical abortion in missed abortion of woman with complete septate uterus
| Obstetrics & Gynecology Science |
| 2021 | Optimized culture system to maximize ovarian cell growth and functionality in vitro | CELL AND TISSUE RESEARCH |
| 2022 | OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2002 | Osteopontin as apotential diagnostic biomarker for ovarian cancer | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2003 | Osteopontin is down-regulated in hydatidiform mole | GYNECOLOGIC ONCOLOGY |
| 2003 | Outcomes and surgical therapeutic index of Burch colposuspension in stress urinary incontinence | JOURNAL OF REPRODUCTIVE MEDICINE |
| 2019 | Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
| BMC CANCER |
| 2018 | Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
| YONSEI MEDICAL JOURNAL |
| 2016 | Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease
| BMC CANCER |
| 2017 | Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
| YONSEI MEDICAL JOURNAL |
